Skip to main content
Premium Trial:

Request an Annual Quote

Get it Moving

Too many patents don't make it out of universities and into the marketplace, write Ed Paisley and Sean Pool at the Center for American Progress' Science Progress site. While Paisley and Pool note there are many reasons for that limited movement out of the lab, the main one, they say, "is that the federal funding on which much university research depends does not encourage universities to prioritize the commercialization of the resulting technology." The authors suggest that the government should reserve a small percentage of research funding to support the early stages of commercialization, that a program be created to better facilitate coordination between researchers and businesspeople, and that another portion of funding be used to promote entrepreneurship in universities. "Smart federal investments can help many other research universities identify and capitalize on their competitive strengths," Paisley and Pool add.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.